呋虫胺原药
Search documents
海利尔:公司吡虫啉、呋虫胺原药市场面向国内外核心客户
Zheng Quan Ri Bao Zhi Sheng· 2025-12-29 12:36
(编辑 姚尧) 证券日报网讯 12月29日,海利尔在互动平台回答投资者提问时表示,公司吡虫啉、呋虫胺原药市场面 向国内外核心客户,提供全链条植保服务,依托"原药+制剂"一体化优势,为水稻、小麦、果树等主流 作物提供病虫草害全周期防控解决方案。 ...
海利尔(603639.SH):暂无四氟醚菊酯原药
Ge Long Hui A P P· 2025-11-28 07:59
Core Viewpoint - The company, Hailier (603639.SH), currently does not produce the active ingredient for four-fluoro ether pyrethroid and has no specific mosquito control formulations [1] Group 1: Product Information - The company's active ingredients, imidacloprid and acetamiprid, have certain efficacy against mosquitoes [1] - The project for producing 1,500 tons of acetamiprid annually in Qingdao Hengning is set to enter trial production in December 2024 [1] - Combined sales revenue from imidacloprid and acetamiprid is expected to account for less than 10% of the company's total revenue in 2024 [1]